AddLife AB
Sweden · SE0014401378 · reports in SEK · Europe
The answers
From the annual report for the year to Dec 31, 2025. Each line says what it is based on.
- Is it growing?Fair
- Revenue +1.5% in the year to Dec 31, 2025, on the year before.
- Is it a good business?Fair
- It earned 10% on its shareholders' equity in the year to Dec 31, 2025.
- Is it safe?Fair
- Equity is 43% of its assets, and operations brought in cash in the year.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2025, consolidated, in SEK.
revenue
operating margin
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|
| Revenue | SEK 9.1B | n/a | SEK 10.3B | SEK 10.4B |
| Operating profit | SEK 808M | SEK 585M | SEK 721M | SEK 993M |
| Net profit to shareholders | SEK 480M | SEK 190M | SEK 252M | SEK 560M |
| Earnings per share | SEK 3.96 | SEK 1.56 | SEK 2.06 | SEK 4.59 |
| Cash from operations | SEK 909M | SEK 773M | SEK 1.1B | SEK 1.4B |
| Capital spending | SEK 213M | SEK 226M | SEK 250M | SEK 242M |
| Cash | SEK 376M | SEK 272M | SEK 331M | SEK 813M |
| Total assets | SEK 13.1B | SEK 12.7B | SEK 13.1B | SEK 12.7B |
| Equity | SEK 5.0B | SEK 5.0B | SEK 5.3B | SEK 5.4B |
What they do
In the company's own words, from the annual report.
Koncernen är en ledande oberoende leverantör av utrustning, instrument ochreagenser från ledande globala leverantörer till kunder främst inom sjukvård, forskning, universitet och högskolor samt läkemedels- ochlivsmedelsindustrin.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.